The mission of the Palobiofarma is to discover new drugs based on the modulation of adenosine receptors
The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.
Palobiofarma focused internal resources on areas where lies the experience of the management team::
The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.